EUVIMEDEUVIMED entdecken
Crossref

L26/O-326 Lipiodol hysterosalpingography modulates endometrial extracellular vesicle signalling and lipid composition during the window of implantation: the NOEL study

Y.C. Cheong, M. Rutt, A. Kermack, R. Lewis, J. Cleal

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y.C. Cheong und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does Lipiodol hysterosalpingography (HSG) induce measurable biological changes in the human endometrium that could explain its fertility-enhancing effect? Summary answer Lipiodol hysterosalpingography reduces endometrial extracellular vesicle abundance and increases phosphatidylcholine and triacylglycerides during implantation, without detectable changes in endometrial or vesicle microRNA expression in vivo. What is known already Oil-based contrast HSG increases spontaneous pregnancy rates compared with water-based contrast, but the underlying mechanism remains poorly understood. Proposed explanations extend beyond tubal flushing to include immunological and endometrial effects. Endometrial extracellular vesicles play a key role in embryo–endometrial communication, yet their modulation following Lipiodol exposure has not previously been studied in humans. Study design, size, duration Prospective longitudinal mechanistic study with paired endometrial fluid and tissue sampling before and one month after Lipiodol HSG in 15 women, conducted over 18 months. Participants/materials, setting, methods Twenty-four women undergoing HSG for subfertility were recruited; fifteen completed paired endometrial fluid and tissue sampling during the window of implantation pre- and post-HSG. Extracellular vesicles in uterine fluid were quantified and phenotyped by flow cytometry. Vesicle-associated miRNA and endometrial tissue mRNA/miRNA were analysed by next-generation sequencing. Endometrial lipid composition was assessed by gas chromatography. Parallel ex vivo endometrial organoid experiments were conducted to explore mechanistic replication. Main results and the role of chance Endometrial extracellular vesicle (EV) concentration decreased significantly following Lipiodol hysterosalpingography (HSG), with a mean reduction of 28% compared with pre-HSG levels (2026 vs 1457 vesicles/µl; p < 0.05). EV size did not differ before and after HSG, suggesting altered vesicle abundance rather than changes in vesicle biogenesis or morphology. Sequencing of vesicle-associated microRNA and matched endometrial tissue mRNA and microRNA revealed no differentially expressed transcripts following Lipiodol exposure. Gas chromatography demonstrated significant post-HSG increases in endometrial phosphatidylcholine and triacylglyceride content (both p = 0.02), indicating a shift in endometrial lipid composition during the window of implantation. Seven participants conceived spontaneously within six months of undergoing Lipiodol HSG, consistent with previously reported fertility benefits of oil-based contrast, although the study was not powered to assess reproductive outcomes. In contrast to in vivo findings, short-term Lipiodol exposure of endometrial organoids did not reproduce changes in EV abundance, size, lipid composition or gene expression. This discrepancy may reflect the importance of systemic, temporal or cell heterogeneity not captured in the ex vivo organoid model. Limitations, reasons for caution The study was not powered for fertility outcomes and the sample size limits detection of subtle transcriptomic changes. Sampling at one month post-HSG may have missed transient early molecular effects. The organoid model lacks full stromal-immune integration and prolonged exposure. Wider implications of the findings These findings challenge the view of Lipiodol HSG as a purely mechanical intervention and provide evidence for a biologically active effect on the endometrium. Modulation of vesicle signalling and lipid composition may represent novel mechanisms influencing receptivity and implantation, with implications for patient stratification and future therapeutic targeting. Trial registration number No

Zitieren

APA

Cheong, Y., Rutt, M., Kermack, A., Lewis, R., & Cleal, J. (2026). L26/O-326 Lipiodol hysterosalpingography modulates endometrial extracellular vesicle signalling and lipid composition during the window of implantation: the NOEL study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.324

Vancouver

Cheong Y, Rutt M, Kermack A, Lewis R, Cleal J. L26/O-326 Lipiodol hysterosalpingography modulates endometrial extracellular vesicle signalling and lipid composition during the window of implantation: the NOEL study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.324

BibTeX
@article{Cheong2026,
  author = {Cheong, Y.C. and Rutt, M. and Kermack, A. and Lewis, R. and Cleal, J.},
  title = {L26/O-326 Lipiodol hysterosalpingography modulates endometrial extracellular vesicle signalling and lipid composition during the window of implantation: the NOEL study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.324}
}
Kostenlos starten →